Streamline Health Solutions (NASDAQ:STRM) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report released on Tuesday. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Performance

Shares of Streamline Health Solutions stock opened at $2.78 on Tuesday. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66. Streamline Health Solutions has a twelve month low of $1.85 and a twelve month high of $9.75. The stock has a market cap of $11.73 million, a price-to-earnings ratio of -0.56 and a beta of 1.64. The company’s fifty day moving average is $2.62 and its 200 day moving average is $5.34.

Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%. The business had revenue of $4.48 million during the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.